Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience

被引：11

作者：

Scalvenzi, Massimiliano ^{[1
]}

Patri, Angela ^{[1
]}

Costa, Claudia ^{[1
]}

Megna, Matteo ^{[1
]}

Napolitano, Maddalena ^{[2
]}

Fabbrocini, Gabriella ^{[1
]}

Balato, Nicola ^{[1
]}

机构：

[1] Univ Naples Federico II, Dept Dermatol, Naples, Italy

[2] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy

来源：

DERMATOLOGY AND THERAPY | 2019年 / 9卷 / 02期

关键词：

Keratoacanthoma; Methotrexate; Nonsurgical treatment;

D O I：

10.1007/s13555-019-0286-1

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Introduction: Keratoacanthomas are cutaneous neoplasms known for their rapid growth and spontaneous regression over a long time period. Their treatment can be difficult because of the potentially large field size and number of lesions. Intralesional methotrexate constitutes an effective, nonsurgical treatment of keratoacanthomas, as proven by our experience. Methods: We treated 11 elderly patients affected by keratoacanthoma with intralesional methotrexate. The injections were performed weekly, followed by 10 mg of folic acid to be taken 24 h later. Results: All our patients underwent complete resolution of the lesions after 4-8 injections, without side effects. Conclusion: Intralesional methotrexate seems to be an effective and safe nonoperative treatment modality for keratoacanthoma, especially when it arises in anatomic areas difficult to treat with surgery, in elderly debilitated patients, and in those refusing surgery.

引用

页码：369 / 372

页数：4

共 10 条

[1] Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literature
Annest, Nicole M.
VanBeek, Marta J.
Arpey, Christopher J.
Whitaker, Duane C.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (06) : 989 - 993
[2] Costa C, 2018, G ITAL DERMATOLVENER, DOI [10.23736/S0392-0488.18.06144-8, DOI 10.23736/S0392-0488.18.06144-8]
[3] Intralesional chemotherapy for nonmelanoma skin cancer: A practical review
Kirby, Joslyn S.
Miller, Christopher J.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (04) : 689 - 702
[4] KERATOACANTHOMAS TREATED WITH MOHS MICROGRAPHIC SURGERY (CHEMOSURGERY) - A REVIEW OF 43 CASES
LARSON, PO
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (05) : 1040 - 1044
[5] Clinical trial: intralesional infiltration of methotrexate as neoadjuvant in the keratoacanthoma surgery allows to obtain better aesthetic and functional results
Martorell-Calatayud, A.
Requena, C.
Nagore, E.
Sanmartin, O.
Serra-Guillen, C.
Botella-Estrada, R.
Sanz-Motilva, V.
Llombart, B.
Alcaniz-Moscardo, A.
Guillen-Barona, C.
[J]. ACTAS DERMO-SIFILIOGRAFICAS, 2011, 102 (08): : 605 - 615
[6] THE PHARMACOLOGY OF METHOTREXATE
OLSEN, EA
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (02) : 306 - 318
[7] Remling R, 2000, HAUTARZT, V51, P612, DOI 10.1007/s001050051180
[8] Stranc M F, 1979, Ann Plast Surg, V2, P525, DOI 10.1097/00000637-197906000-00013
[9] Veerula VL, 2016, CUTIS, V98, pE12
[10] Intralesional Methotrexate for the Treatment of Keratoacanthoma: Retrospective Study and Review of the Korean Literature
Yoo, Min Gun
Kim, Il-Hwan
[J]. ANNALS OF DERMATOLOGY, 2014, 26 (02) : 172 - 176

← 1 →